Courses
ASNR19 OnDemand

ASNR19 OnDemand

Description & Learning Objectives

This content was originally presented during the 2019 ASNR Annual Meeting in Boston, MA, May 18-22, 2019.

Upon completion of this activity, participants will gain strategies to:
-Discuss neuroimaging adding value in clinical care by improving health outcomes and healthcare delivery.
-Evaluate imaging and determine patient management and treatment.
-Describe ways to improve quality and safety in neuroimaging.
-Review methods to improve patient outcomes utilizing advanced neuroimaging.

Instructions for Participation

To complete this activity, learners will watch a recording of a live conference session and submit a course evaluation. Once all elements are completed, a certificate will be automatically added to your transcript.

Credit Dates

Available: 1/1/2024
Expires: 12/31/2026

Planners & Faculty

ASNR would like to thank the following individuals for planning this activity:
Robert M. Barr, MD, FACR, 2019 Program Chair/President-Elect
Mark E. Mullins, MD, PhD, ASNR Education Committee Chair

Accreditation Statement

The American Society of Neuroradiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Neuroradiology designates this enduring material for a maximum of 43.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure

In compliance with ACCME requirements and guidelines, ASNR has developed a policy for disclosure and review of potential conflicts of interest and a method for resolution if a conflict does exist. ASNR maintains a tradition of scientific integrity and objectivity in its educational activities. In order to preserve these values and ensure its educational activities are independent and free of commercial bias, all individuals, including planners, presenters, moderators and evaluators, participating in an ASNR educational activity, or an activity jointly provided by ASNR must disclose all relevant financial relationships with ineligible companies, as defined by the ACCME. Unless listed below, all planners and individuals in control of content have nothing to disclose.

Albers, Greg: Pfizer (Consultant); Phillips Healthcare (Consultant); Portola (Research Grant Site Principal Investigator); CSL Behring (Consultant); Octapharma (Consultant)
Chang, Peter: Siemens Healthineers (Employee).
Chen, James: NIH (Research Grant Site Principal Investigator); Medtronic (Other Financial or Material Support).
Dabus, Guilherme: Penumbra (Speaker/teaching arrangement).
Forghani, Reza: AB Elekta (Stock Shareholder).
Kanal, Emanuel: Tocagen, Other Financial or Material Support
Kantarci, Kejal: GE Healthcare (Consultant); Siemens (Consultant); Medtronic (Consultant).
Lee, Ryan: Varian Medical Systems (Research Grant Site Principal Investigator).
Lev, Michael: Elsevier (Consultant).
Liew, Sook-Lei: Merit (Consultant, Speakers Bureau); Medtronic (Consultant); Galil/BTG (Consultant).
Moran, Christopher: GalileoCDS (Founder).
Mukherjee, Pratik: GE Healthcare (Research Grant Site Principal Investigator).
Puri, Ajit: SpineThera (Stock Shareholder, Scientific/Medical Advisory Board Member).
Sanelli, Pina: CereScan/CereMetrix (Employee).
Seidenwurm, David: GE Healthcare (Research Grant Site Principal Investigator).
Shepherd, Timothy: Niji Corp. (Stock Shareholder, Scientific/Medical Advisory Board Member, Consultant, Founder).
Watanabe, Alyssa: Airsmed (Stock Shareholder, Consultant).
Weiner, Michael: Subtle Medical (Employee).
Yang, Edward: Medtronic (Consultant).
Yousem, David: Biogen (Speaker/teaching arrangement).
Zaharchuk, Gregory: Siemens (Other Financial or Material Support).